| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.289 | 20.953 | 959 | 54.525 | - | - | - | - | - | - |
| Total Income - EUR | 37.289 | 26.279 | 1.107 | 60.898 | - | - | - | - | - | - |
| Total Expenses - EUR | 26.051 | 25.091 | 5.320 | 4.046 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 11.238 | 1.189 | -4.214 | 56.852 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 10.120 | 620 | -4.247 | 56.231 | - | - | - | - | - | - |
| Employees | 0 | 1 | 1 | 1 | - | - | - | - | - | - |
Check the financial reports for the company - Farmacia Alissa Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Current Assets | 13.529 | 28.330 | 23.508 | 73.697 | - | - | - | - | - | - |
| Inventories | 11.569 | 13.296 | 11.944 | 11.725 | - | - | - | - | - | - |
| Receivables | 1.860 | 14.848 | 11.565 | 61.126 | - | - | - | - | - | - |
| Cash | 100 | 186 | 0 | 846 | - | - | - | - | - | - |
| Shareholders Funds | -20.313 | -19.486 | -23.403 | 33.258 | - | - | - | - | - | - |
| Social Capital | 67 | 67 | 66 | 64 | - | - | - | - | - | - |
| Debts | 33.842 | 47.816 | 46.911 | 40.439 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Alissa Laboratory S.r.l.